Expanded VGLL1-specific CTLs not only recognized and killed a panel of allogenic PDAC tumor lines, but also demonstrated reactivity against A*0101-expressing tumor cells derived from five other cancer types. This evidence concerns the gene VGLL1 and neoplasm.